GL China Long Equity Opportunities Fund LP - Net Worth and Insider Trading
GL China Long Equity Opportunities Fund LP Net Worth
The estimated net worth of GL China Long Equity Opportunities Fund LP is at least $322 Million dollars as of 2025-01-15. GL China Long Equity Opportunities Fund LP is the 2201 Interest of corporation controlled by you of Consun Pharmaceutical Group Ltd and owns about 42,907,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) stock worth over $322 Million. Details can be seen in GL China Long Equity Opportunities Fund LP's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that GL China Long Equity Opportunities Fund LP has not made any transactions after 2024-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of GL China Long Equity Opportunities Fund LP
GL China Long Equity Opportunities Fund LP Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, GL China Long Equity Opportunities Fund LP owns 1 companies in total, including Consun Pharmaceutical Group Ltd (HKSE:01681) .
Insider Ownership Summary of GL China Long Equity Opportunities Fund LP
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01681 | Consun Pharmaceutical Group Ltd | 2024-11-08 | 2201 Interest of corporation controlled by you |
GL China Long Equity Opportunities Fund LP Latest Holdings Summary
GL China Long Equity Opportunities Fund LP currently owns a total of 1 stock. GL China Long Equity Opportunities Fund LP owns 42,907,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) as of November 5, 2024, with a value of $322 Million.
Latest Holdings of GL China Long Equity Opportunities Fund LP
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01681 | Consun Pharmaceutical Group Ltd | 2024-11-05 | 42,907,000 | 7.50 | 321,802,500 |
Holding Weightings of GL China Long Equity Opportunities Fund LP
GL China Long Equity Opportunities Fund LP Form 4 Trading Tracker
According to the SEC Form 4 filings, GL China Long Equity Opportunities Fund LP has made a total of 1 transactions in Consun Pharmaceutical Group Ltd (HKSE:01681) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Consun Pharmaceutical Group Ltd is the acquisition of 491,000 shares on November 5, 2024, which cost GL China Long Equity Opportunities Fund LP around $4 Million.
Insider Trading History of GL China Long Equity Opportunities Fund LP
- 1
GL China Long Equity Opportunities Fund LP Trading Performance
GuruFocus tracks the stock performance after each of GL China Long Equity Opportunities Fund LP's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by GL China Long Equity Opportunities Fund LP is %. GuruFocus also compares GL China Long Equity Opportunities Fund LP's trading performance to market benchmark return within the same time period. The performance of stocks bought by GL China Long Equity Opportunities Fund LP within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how GL China Long Equity Opportunities Fund LP's insider trading performs compared to the benchmark.
Performance of GL China Long Equity Opportunities Fund LP
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.73 |  | | | | |
| Relative Return to S&P 500(%) | -6.79 | | | | | |
GL China Long Equity Opportunities Fund LP Ownership Network
Ownership Network List of GL China Long Equity Opportunities Fund LP
Ownership Network Relation of GL China Long Equity Opportunities Fund LP
GL China Long Equity Opportunities Fund LP Owned Company Details
What does Consun Pharmaceutical Group Ltd do?
Who are the key executives at Consun Pharmaceutical Group Ltd?
GL China Long Equity Opportunities Fund LP is the 2201 Interest of corporation controlled by you of Consun Pharmaceutical Group Ltd. Other key executives at Consun Pharmaceutical Group Ltd include 2201 Interest of corporation controlled by you Assicurazioni Generali SpA , 2201 Interest of corporation controlled by you Li Zhenfu , and 2101 Beneficial owner An Meng .
Consun Pharmaceutical Group Ltd (HKSE:01681) Insider Trades Summary
Over the past 18 months, GL China Long Equity Opportunities Fund LP made 1 insider transaction in Consun Pharmaceutical Group Ltd (HKSE:01681) with a net purchase of 491,000. Other recent insider transactions involving Consun Pharmaceutical Group Ltd (HKSE:01681) include a net sale of 9,219,000 shares made by Li Qian , a net sale of 9,219,000 shares made by An Yubao , and a net purchase of 491,000 shares made by Assicurazioni Generali SpA .
In summary, during the past 3 months, insiders sold 0 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) in total and bought 1,473,000 shares, with a net purchase of 1,473,000 shares. During the past 18 months, 18,438,000 shares of Consun Pharmaceutical Group Ltd (HKSE:01681) were sold and 1,657,000 shares were bought by its insiders, resulting in a net sale of 16,781,000 shares.
Consun Pharmaceutical Group Ltd (HKSE:01681)'s detailed insider trading history can be found in Insider Trading Tracker table.
Consun Pharmaceutical Group Ltd Insider Transactions
GL China Long Equity Opportunities Fund LP Mailing Address
Above is the net worth, insider trading, and ownership report for GL China Long Equity Opportunities Fund LP. Currently GuruFocus does not have mailing address information for GL China Long Equity Opportunities Fund LP.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
